# Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

> **NCT07036016** · — · COMPLETED · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 67818 (actual)

## Conditions studied

- Non-Small Cell Lung Cancer (NSCLC)

## Interventions

- **DRUG:** EGFR-TKI
- **DRUG:** PD-1/PD-L1 inhibitor
- **DRUG:** EGFR-TKI combined with PD-1/PD-L1

## Key facts

- **NCT ID:** NCT07036016
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-05-01
- **Target enrollment:** 67818 (ACTUAL)
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07036016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07036016, "Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07036016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*